.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ERYTHROCIN STEARATE Drug Profile

« Back to Dashboard
Erythrocin Stearate is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from seven suppliers.

The generic ingredient in ERYTHROCIN STEARATE is erythromycin stearate. There are ninety-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.

Summary for Tradename: ERYTHROCIN STEARATE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list7

Pharmacology for Tradename: ERYTHROCIN STEARATE

Clinical Trials for: ERYTHROCIN STEARATE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc
ERYTHROCIN STEARATE
erythromycin stearate
TABLET;ORAL060359-002Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Arbor Pharms Llc
ERYTHROCIN STEARATE
erythromycin stearate
TABLET;ORAL060359-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Arbor Pharms Llc
ERYTHROCIN STEARATE
erythromycin stearate
TABLET;ORAL060359-003Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc